Türkez Hasan, Geyikoglu Fatime, Yousef Mokhtar Ibrahim
Department of Biology, Atatürk University, Erzurum, Turkey.
Toxicol Ind Health. 2012 Sep;28(8):687-96. doi: 10.1177/0748233711420475. Epub 2011 Oct 13.
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is an environmental contaminant that leads to the development of hepatotoxicity. Docosahexaenoic acid (DHA) has been proposed to counteract oxidative stress and improve antioxidant status, and several studies suggest that supplementations with antioxidants can influence hepatotoxicity. The aim of the current study was to explore the role of DHA in modulating the toxicity of TCDD in the liver of Sprague-Dawley rats. Animals were assigned to four groups (n = 5): control (only dimethyl sulfoxide (DMSO)), 8 μg/kg body weight (b.w.) TCDD in DMSO solution; 250 mg/kg b.w. DHA and TCDD plus DHA; respectively. Rats were intraperitoneally administered their respective doses daily for 21 days. On day 21, the animals were killed, and then biochemical tests, pathological examination, and micronucleus (MN) assay were performed in the liver. Our results showed that the activities of antioxidant enzymes were significantly decreased and serious pathological findings were established in rats that received TCDD. Beside the rate of MNs in hepatocytes was increased after the treatment with dioxin. In rats treated with DHA alone, MNs were not changed and the activities of antioxidant enzymes were significantly increased. The presence of DHA with TCDD alleviated its pathological effects in hepatic tissue. DHA also prevented the suppression of antioxidant enzymes in the livers of animals exposed to TCDD and displayed a strong protective effect against MNs. It can be concluded that DHA has beneficial influences and could be able to antagonize TCDD toxicity in liver.
2,3,7,8-四氯二苯并-对-二噁英(TCDD)是一种会导致肝毒性的环境污染物。二十二碳六烯酸(DHA)被认为可以对抗氧化应激并改善抗氧化状态,并且多项研究表明补充抗氧化剂会影响肝毒性。本研究的目的是探究DHA在调节TCDD对Sprague-Dawley大鼠肝脏毒性中的作用。将动物分为四组(每组n = 5):对照组(仅给予二甲基亚砜(DMSO));8 μg/kg体重的TCDD溶于DMSO溶液中;250 mg/kg体重的DHA以及TCDD加DHA组。大鼠每天腹腔注射各自的剂量,持续21天。在第21天,处死动物,然后对肝脏进行生化检测、病理检查和微核(MN)试验。我们的结果显示,接受TCDD的大鼠体内抗氧化酶活性显著降低,并出现了严重的病理表现。此外,用二噁英处理后肝细胞中的微核率增加。单独用DHA处理的大鼠,微核未发生变化,抗氧化酶活性显著增加。DHA与TCDD同时存在可减轻其在肝组织中的病理作用。DHA还可防止暴露于TCDD的动物肝脏中抗氧化酶受到抑制,并对微核表现出强大的保护作用。可以得出结论,DHA具有有益影响,并且能够拮抗TCDD对肝脏的毒性。